LabAnywhere: Technology for Detection of Coronavirus in Remote Settings

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 170657

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $253,591.28
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principle Investigator

    Pending
  • Research Location

    Canada, Americas
  • Lead Research Institution

    University of Prince Edward Island
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The COVID-19 disease is caused by a virus. Since the symptoms of the COVID-19 disease are similar to many other illnesses, accurate detection and correct identification of the virus in a patient is important to know whether or not the patient is suffering from COVID-19 versus another disease. The current gold-standard detection uses sophisticated molecular biology that must be done in a laboratory by trained technicians. Our research team has developed LabAnywhere, a system intended for rugged use in agriculture. Its called LabAnywhere because it is designed for use in a barn or farm field where there may not be any clean enclosed space to do complex sample handling. The viruses are different in veterinary medicine, but with some modifications, the technology can be applied to human diseases in remote settings. The proposed research will piggyback upon existing projects. The research team; a design engineer, along with experts in medical biophysics, protein chemistry, and veterinary diseases have been testing a pen-side system for the livestock industries. The design is a simple, easy to deploy handheld system for a molecular biologic assay where there is no laboratory available, such as on a ship at sea or in a remote community many days travel from a laboratory. The project will use easily handled, safe viruses from the animal world for initial testing to validate the methods, then move to tests using human viruses once initial trials are complete.